What is the UK's science and health research role after Brexit?
2021 will be a pivotal year for British diplomacy, with the UK hosting the G7 presidency and co-chairing the COP26 conference. Both will be opportunities to introduce Global Britain to the world stage and take place in the context of the Covid-19 pandemic which has shown the potential benefits of deepening international research collaboration.
At this timely event, the panel explored what Global Britain means for the UK’s research agenda: how can the UK best combine its scientific knowledge with diplomatic strength to maximise its impact on the international stage? And how could the UK use its global influence, to achieve this?
On our panel to discuss these questions were:
Rt Hon Lord Johnson of Marylebone, former Minister of State for Universities, Science, Research and Innovation
Pascal Lamy, former Director General of the World Trade Organization
Dr Beth Thompson, Head of Policy and Advocacy – UK and EU at Wellcome Trust
Dr Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry
The event was chaired by Dr Hannah White, Deputy Director of the Institute for Government.
